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p33ING1, which encodes a 33-kD nuclear protein, was cloned by
subtractive hybridization and subsequent selection of transforming
genetic suppressor elements (Garkavtsev et al, 1996).
Overexpression of the sense ING1 inhibits cell growth
(Garkavtsev et al, 1996). Specifically, flow cytometry analysis
shows that normal fibroblasts transfected with the ING1 gene are
arrested in the G0/G1 phase of the cell cycle (Garkavtsev et al,
1996). It is observed that this ING1-induced arrest is achieved by
up-regulating  p53-dependent activation of the p21waf1 promoter
(Garkavtsev et al, 1998). It is further noted that neither ING1 nor
p53 alone can exert arrest and that both proteins can physically
associate with one another, as demonstrated by immunoprecipita-
tion (Garkavtsev et al, 1998). In addition to the function of cell
growth arrest, ING1 has been found to play a role in senescence
(Garkavtsev et al, 1997). Expression of ING1 is 8- to 10-fold
higher in senescent cells than in young proliferation-competent
human diploid fibroblasts. Cells expressing antisense ING1 can
increase their replicative life by 7-fold. In apoptosis, Helbing and
colleagues (1997) reported that elevated expression of ING1
enhances serum starvation-induced cell death in p19 mouse terato-
carcinoma and NIH 3T3 cells. Recently, another report demon-
strates that apoptosis can be enhanced by adenovirus-mediated
transfer of both ING1 and  p53, further underscoring the inter-
dependent relationship between the two genes (Shinoura et al, 1999).
Evidence also suggests that ING1 is capable of sensitizing cells to
chemotherapeutic agents, such as etoposide and γ -irradiation
(Garkavtsev et al, 1998). Although the mechanism of such sensi-
tizing ability is unclear, its apoptotic function may be involved.
p53, which encodes a nuclear protein, regulates a number of
downsteam targets such as p21waf1, GADD45, bax, and bcl-2 and
carries out tumour suppressive functions, much like ING1. Studies
over more than a decade indicate that p53 is a key mediator of cell
cycle regulation, apoptosis, DNA repair, senescence, and sensiti-
zation to chemotherapeutic agents (Bond et al, 1994; Miyashita et
al, 1994; Smith et al, 1994; Li et al, 1997; 2000; Bunz et al, 1998).
Regarded as a ‘guardian of the genome’, p53 holds the title of
being the most frequently mutated gene known to date (Hollstein
et al, 1991). More than 50% of human malignancies of epithelial,
mesenchymal, haematopoietic, lymphoid, and central nervous
system origin have been shown to contain a mutated form of p53.
Evidence suggests that loss of normal p53 function is associated
with cell transformation in vitro and the development of
neoplasms in vivo (Finlay et al, 1989). Under stress conditions,
such as those genotoxic in nature, levels of p53 protein rapidly
increase in the cell. The upregulation induces the expression of
p21waf1, a potent inhibitor of cyclin-dependent kinase activity,
which inhibits cell cycle progression from G0 to S phase (Shaulsky
et al, 1991; El-Deiry et al, 1993). It has also been demonstrated
that p53 maintains genomic stability by enhancing DNA repair
and apoptosis. We recently demonstrated that loss of wild-type
p53 function results in reduced DNA repair and apoptosis in
mouse keratinocytes and fibroblasts after UV irradiation (Li et al,
1996; 1997; 1998a; Tron et al, 1998a; 1998b). As a result of
reduced DNA repair and apoptosis, mice with abnormal p53 func-
tion, either by gene knockout or overexpression of mutant p53, are
predisposed to UV-induced skin cancer development (Li et al,
1995; 1998b).
To further our understanding of the relationship between p53
and  ING1, we first investigated how the expression of ING1
behaves in the context of p53 using a knockout mouse model. We
also looked at whether ING1 expression relies on the status of p53
in UV-irradiated conditions. Our results indicate that ING1 expres-
sion is independent of wild-type p53 function and that ING1 may
play a role in cellular stress response and skin carcinogenesis.
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Summary A recently cloned tumour suppressor candidate, p33ING1, has been shown in vitro to collaborate with p53 to execute growth arrest
and apoptosis. However, it is unclear as to how the expression of ING1 is regulated in normal and stress conditions. Using a p53-knockout
mouse model, we investigated if the expression of ING1 was dependent on p53. We found that there was no difference in ING1 mRNA and
protein levels between p53+/+ and p53–/– murine organs. In addition, when normal human epithelial keratinocytes (NHEK) and a keratinocyte
cell line, HaCaT, which lacks wild-type p53 function, were exposed to UVB irradiation, the expression levels of ING1 were elevated in both
NHEK and HaCaT cells. It is interesting, however, that UVB irradiation did not induce ING1 expression in dermal fibroblasts isolated from
p53+/+ and p53–/– mice. Based on our findings, we therefore conclude that the expression of ING1 is independent of p53 status. UV
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MATERIALS AND METHODS
Animals
p53+/+ and p53–/– mice were purchased from Taconic (New York,
NY, USA). p53–/– mice carried a disrupted, nonfunctional p53
gene, created by homologous recombination in an embryonic stem
cell line and by microinjection of the stem cells into 3.5-day-old
C57BL/6 blastocysts (Donehower et al, 1992).
Cell culture
Normal human epithelial keratinocytes (NHEK) were obtained
from the Tissue Bank of Vancouver General Hospital. They were
maintained in Keratinocyte-SFM medium (Canadian Life
Technologies, Burlington, Ontario, Canada). Human HaCaT
keratinocytes (kindly provided by Dr NE Fusenig, DKFZ,
Heidelberg, Germany) were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 5% fetal calf
serum (Canadian Life Technologies), 100 units ml–1 penicillin and
100 µ g ml–1 streptomycin at 37° C in a 5% CO2 atmosphere.
Dermal fibroblasts of p53+/+ and p53–/– mice were isolated from
4-week-old mice. The mice were sacrificed by cervical dislocation
and a 2 × 2 cm skin biopsy was dissected from the dorsal area. The
hair was removed and the skin biopsy was disinfected with 2.5%
betadine for 1 min, followed by 1 min in 70% ethanol, and washed
with phosphate buffered saline (PBS) twice. The skin tissue was
then minced and incubated in DMEM containing 200 units ml–1
collagenase (Sigma, St Louis, MO, USA) at 37° C for 6 h. The
digested skin tissue was centrifuged at 1000 rpm for 10 min and
the pellet washed with pre-warmed DMEM twice. The cells were
resuspended in DMEM containing 10% FBS and incubated at
37° C in a 5% CO2 atmosphere.
UVB irradiation
Medium was removed and the cells were exposed to UVB
(290–320 nm) using a bank of four unfiltered FS40 sunlamps
(Westinghouse, Bloomfield, NJ, USA). The intensity of the UV
light was measured by the IL 700 radiometer fitted with a WN 320
filter and an A127 quartz diffuser (International Light,
Newburyport, MA, USA). Medium was replaced and cells were
incubated in a 5% CO2 incubator at 37° C after UVB irradiation.
RT-PCR
Total RNA was extracted by TriZol reagent (Canadian Life
Technologies) and the concentrations were determined by UV
spectrophotometry. 5 µ g of total RNA was reverse-transcribed into
cDNA in the presence of 10 units µ l–1 of SUPERSCRIPT II RNase
H– Reverse Transcriptase (Canadian Life Technologies), 5X first-
strand buffer (250 mM Tris-HCl, pH 8.3, 375 mM KCl, 15 mM
MgCl2), 100 mM DTT, 10 mM dNTP mix (10 mM each of dATP,
dGTP, dCTP and dTTP at pH 7.0), and 2 pmole of the forward
primer (5′ -GATCCTGAAGGAGCTAGACG-3′ ) in a total volume
of 20 µ l. The RT mix was then incubated at 42° C for 2 min. The
reaction was inactivated by heating at 70° C for 15 min. The 100 µ l
of PCR reaction contained 10% of the first-strand reaction, 10X
PCR buffer (200 mM Tris-HCL, pH 8.4, 500 mM KCl), 50 mM
MgCl2, 10 mM dNTP Mix, 10 µ M of the forward primer
(5′ -GATCCTGAAGGAGCTAGACG-3′ ) and 10 mM of the
reverse primer (5′ -AGAAGTGGAACCACTCGATG-3′ ), and
5 units µ l–1 of the Taq DNA polymerase. Amplification was
carried out as follows: 1. initial denaturation at 94° C for 3 min;
2. denaturation at 95° C for 45 s; 3. annealing at 50° C for 1 min;
4. polymerization at 72° C for 2 min; 5. repeat of steps 2–4 for 40
cycles; and 6. final polymerization at 72° C for 5 min. Samples
were then electrophoresed on 1% agarose gels containing
0.5 µ g ml–1 of ethidium bromide and visualized under UV light.
Reaction mix with pCI-ING1 plasmid DNA (kind gift from Dr K
Riabowol, University of Calgary, USA) was used as a positive
control. For semi-quantitative PCR, 2 µ l of the cDNA samples
from reverse transcription were diluted at 10–1 and 100–1. They
were then amplified by PCR as described above.
Northern blot analysis
Total RNA was extracted by TriZol reagent and the concentrations
were determined by UV spectrophotometry. Samples were heated
to 65° C and run on 1% agarose gels containing formaldehyde and
0.5 µ g ml–1 ethidium bromide. After separation, capillary transfer
to nitrocellulose was performed overnight at room temperature
and its efficiency assessed by UV light. The blot was then baked
for 2 h in a vaccum oven at 80° C. Pre-hybridization was carried
out by incubating the blot with a mixture containing 6X SSPE, 5X
Denhardt’s reagent, 0.5% SDS, and 100 µ g ml–1 yeast tRNA for
1 h at 65° C. The ING1 probe was first made by amplifying a
577-bp fragment by PCR using primer 1 (5′ -GATCCTGAAG-
GAGCTAGACG-3′ ) and primer 2 (5′ -AGAAGTGGAAC-
CACTCGATG-3′ ) and then labelling it with α -32 P[dCTP]
(10 mCi ml–1) according to the manufactured protocol in the
Random Primers DNA Labeling System (Canadian Life
Technologies). Hybridization was done by incubating the blot with
the labelled probe at 65° C for 16–24 h. Filters were washed with
2X SSC/0.1% SDS once for 15 min at room temperature and three
washes 20 min each at 65° C. Blots were visualized on X-ray films
after an overnight exposure.
Western blot analysis
Cells were harvested by scraping and solubilized by the Triple
detergent lysis buffer containing 50 mM Tris-Cl pH 8.0, 150 mM
NaCl, 0.02% sodium azide, 0.1% sodium dodecylsulphate, 1%
Nonidet P-40, 100 µ g ml–1 phenylmethylsulphonyl fluoride,
1 µ g ml–1 aprotinin, 1 µ g ml–1 leupeptins and 1 µ g ml–1 pepstatin
A. Concentrations of proteins were determined by the DC Protein
Assay (BioRad, Mississauga, Ontario, Canada). 50 µ g lane–1 of
proteins were separated on 10% polyacrylamide/SDS gels and
electroblotted onto a nitrocellulose filter. The filter was then
blocked with 5% skimmed milk for 1 h and incubated with 1:2000
polyclonal rabbit p33ING1 antibody (PharMingen, Mississauga,
Ontario, Canada) for 1 h at room temperature, followed by three
washes with PBS 0.02% Tween-20 (PBS-T). The filter was then
incubated with 1:10 000 goat anti-rabbit IgG (Calbiochem, San
Diego, CA, USA) at room temperature for 1 h, followed by three
washes with PBS-T. The signals were detected with the ECL
Western blotting detection system (New England Biolab, Guelph,
Ontario, Canada). A 1:2000 dilution of β -actin antibody (Santa
Cruz Biotechnology Inc, Santa Cruz, CA, USA) was used as an
internal control for each blot.1470 K-JJ Cheung Jr et al
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Immunohistochemistry
All samples were frozen-sectioned at six-micron and mounted
onto saline-coated slides. They were then fixed in cold acetone for
2 min. Using the ImmunoCruz Staining Systems (Santa Cruz
Biotechnology Inc) serial sections were first blocked with horse
serum for 20 min, then incubated with 1:500 p33ING1 polyclonal
antibody for 2 h at room temperature, followed by two washes in
PBS each for 2 min. Next, the sections were incubated with biotin-
labelled anti-rabbit secondary antibody with avidin–biotin–peroxi-
dase complex for 30 min, followed by two washes in PBS each for
2 min and staining with the HRP substrate containing DAB chro-
mogen and peroxidase substrate for 30 s to 5 min. Sections were
immediately dehydrated two times in 95% ethanol each for
10 min, two times in 100% ethanol each for 10 s, and three times
in xylenes each for 10 s. Slides were added with permanent
mounting medium, covered with glass coverslip, and observed
under a light microscope.
RESULTS
In vivo expression of ING1 is independent of p53
Studies that have examined the relationship between ING1 and
p53 have mostly been done in vitro (Garkavtsev et al, 1998;
Shinoura et al, 1999). Since p53 is a transcription factor that is
known to initiate a whole host of molecular events by transacti-
vating genes, we investigated if p53 could be an upstream regu-
lator of ING1 by first examining whether ING1 was expressed in
organs from p53+/+ and p53–/– mice. Results from RT-PCR showed
that ING1 was expressed in the brain, liver, lung, heart and skin of
both p53+/+ and p53–/– mice (Figure 1A). Quantitative RT-PCR
indicated that ING1 mRNA levels were virtually equal in the heart
of p53+/+ and p53–/– mice (Figure 1B). The data suggest that ING1
expression is independent of p53 status. To further confirm the
p53-independent expression of ING1, we used Northern blot
analysis to compare mRNA levels in the brain, liver, lung, heart,
skin, kidney, testis, and thymus of p53+/+ and p53–/– mice. Our
results showed that there was no significant difference in ING1
mRNA expression in all eight organs examined (Figure 1C).
Next, we investigated whether p53 status affects ING1 expres-
sion at the post-transcriptional level. We compared ING1 protein
levels in the brain, liver, lung, heart, and skin between p53+/+ and
p53–/– mice. Figure 2 shows that there is no substantial difference
in the levels of 33-kD ING1 protein between p53+/+ and p53–/–
mice in all five organs examined. Recently, two isoforms of the
p33ING1 gene, which encode 47-kD and 24-kD proteins, have been
found (Saito et al, 2000). The anti-ING1 antibody we used
predominantly detected the 33-kD isoform. To confirm the p53-
independent expression of ING1 from the Western analysis, we
used immunohistochemical staining to look at ING1 protein
expression in the brain between the p53+/+ and p53–/– groups. Our
results show that p53+/+ and p53–/– mice have similar levels of
ING1 protein (Figure 3).
UV-induced ING1 expression is independent of p53
p53 plays a significant role in responding to DNA damage. Stress
events, such as ionizing irradiation, ultraviolet light (UV) irradia-
tion and exposure to genotoxic drugs, induce the accumulation of
p53, which then results in cell cycle arrest, DNA repair and/or
apoptosis (El-Diery et al, 1993; Li et al, 1996; 1997; 1998a; Tron
et al, 1998b). Various downsteam p53-mediated targets such as
p21waf1, GADD45, bax, and bcl-2 have been shown to be involved
in these events. To test the hypothesis that ING1 may also be a
downstream target of p53 in stress conditions, we exposed normal
human epithelial keratinocytes (NHEK) and a keratinocyte cell
line (HaCaT), which carries mutated p53 alleles (Lehman et al,
1993), to UVB irradiation and examined the levels of ING1
protein. Our results demonstrate that 33-kD ING1 protein is
induced in both NHEK and HaCaT cells after UVB irradiation
(Figure 4A and 4B). At 40 mJ cm–2, there is a two-fold increase in
the level of ING1 protein in both types of cells. It is also noted that
the expression of ING1 protein in HaCaT cells is dose-dependent,
with a maximum induction at 80 mJ cm–2. The observation of
similar levels of ING1 induction in NHEK and HaCaT cells by UV
irradiation further confirms the p53-independent expression of
ING1.
To confirm that UV induces ING1 expression at the transcrip-
tional level, ING1 mRNA levels were examined in HaCaT cells
over a time-course. Figure 4C shows that ING1 mRNA levels
increase with time, starting at 4 h and peaking at 24 h.
Using human fibroblasts, Garkavtsev and colleagues (1998)
found that DNA damaging agent, adriamycin, did not induce ING1
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Figure 1 Analyses of ING1 mRNA expression of p53+/+ and p53–/– organs.
(A) RT-PCR analysis of mRNA level in different organs of p53+/+ and p53–/–
mice. C1 = negative control without RNA in the reaction. C2 = positive control
with pCI-ING1 plasmid DNA in the reaction. (B) Semi-quantitative RT-PCR
analysis of ING1 mRNA level in the heart of p53+/+ and p53–/– mice. A series
of dilutions of the ING1 cDNA was performed and comparison was made
between the p53+/+ and p53–/– groups. (C) Northern blot analysis of ING1
mRNA expression levels in selected p53+/+ and p53–/– organs. The 18S rRNA
was used as an internal control
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Figure 2 Western blot analysis of ING1 expression levels in selected p53+/+
and p53–/– organs. β -actin was used as internal controlexpression. To determine if UV-induced ING1 in keratinocytes
was tissue-specific, we exposed dermal fibroblasts isolated from
p53+/+ and p53–/– mice to 40 mJ cm–2 of UVB. Our data show that
neither p53+/+ nor p53–/– fibroblasts exhibit any change in ING1
expression (Figure 5). Taken together, we demonstrate that
UV-induction of ING1 is cell type-specific and p53-independent.
DISCUSSION
Our understanding of the biological function of ING1 has
improved over the last 4 years. One of the reasons that this gene
has gained increasing attention from the biological community is
that, though it has no structural similarity with p53, both genes
share many of the tumour suppressive functions, including growth
arrest, apoptosis, senescence and sensitization to drug treatment.
As well, ING1 has been shown to physically associate with p53,
further pointing to the importance of its role in carcinogenesis
(Garkavtsev et al, 1998). Current studies show that overexpression
of ING1 inhibits cell growth, while chronic expression of ING1
antisense constructs promotes cell transformation (Garkavtsev et
al, 1996; 1998). In addition, it was found that the function of cell
growth control is dependent on the activity of both ING1 and p53,
and  p21waf1 has been shown to be their downstream effector
(Garkavtsev et al, 1996; 1998).
Although ING1 shares functional similarities with p53, it is not
known how the expression of ING1 is regulated. Since p53 is a
well-known transcriptional factor for many downstream targets
(El-Deiry et al, 1993; Miyashita and Reed, 1995; Owen-Schaub et
al, 1995), we examined if p53 had an effect on ING1 expression in
both normal and stress environments. Most studies on ING1 came
primarily from in vitro analysis using long-term cultured cell lines.
Since many genetic changes may occur in this type of system, we
chose to use the p53-knockout mouse model for this study. We
compared the ING1 mRNA and protein levels in a number of
organs from p53+/+ and p53–/– mice and no significant difference
was observed in these two groups (Figures 1–3).
We also investigated if ING1 could be induced under stress
conditions where p53 is frequently upregulated (Hall et al, 1993;
Li et al, 1998a). We exposed fibroblasts from p53+/+ and p53–/–
mice, NHEK and a keratinocyte cell line, HaCaT, to UVB and
compared the ING1 protein levels in these cells. HaCaT is a
spontaneously immortalized, non-tumorigenic human keratinocyte
cell line that behaves phenotypically like its normal counterpart in
terms of patterns of growth and differentiation (Boukamp et al,
1988). Besides the advantage of being similar in many respects
with its normal counterpart, this cell line lacks the functional p53
gene, allowing the study of the relationship between p53 and its
associates. Our results indicate that ING1 is induced in both
NHEK and HaCaT cells, regardless of p53 status, further
confirming our previous observation of ING1 p53-independent
expression. The fact that ING1 is not induced in fibroblasts after
UV irradiation suggests that UV-induction of ING1 expression is
cell type-specific, consistent with the data reported by Garkavtsev
and colleagues (1998) where they found no induction of ING1
expression in fibroblasts treated with adriamycin, a chemothera-
peutic drug. Similarly, Zeremski et al (1999) reported that there
was a lack of effect of p53 status on ING1 levels in murine
mammary gland cell lines under normal and stress conditions.
Keratinocyte-specific UVB induction of ING1 may have
biological significance, as keratinocytes are the primary target of
p53-independent expression of p33ING1 1471
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AB
Figure 3 Immunohistochemical analysis of the brain of p53+/+ and p53–/–
mice. (A) p53+/+. (B) p53–/–. Arrows indicate ING1 expressing neural cells.
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Figure 4 ING1 induction by UVB irradiation in keratinocytes. (A) and
(B) Proteins were extracted from the cells 48 h after UVB irradiation and
subjected to Western blot analysis. (A) NHEK were exposed to UVB at 0 and
40 mJ cm–2. (B) HaCaT cells were exposed to UVB at 0, 20, 40, 80, and
100 mJ cm–2. β -actin was used as an internal control. (C) Northern blot
analysis of ING1 expression levels in HaCaT cells. HaCaT cells were
exposed to UVB at 80 mJ cm–2 and total RNA was collected at 0, 1, 2, 4, 8,
24, and 48 h. The 18S rRNA was used as an internal control
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Figure 5 Western blot analysis of ING1 protein in mouse fibroblasts.
p53+/+ and p53–/– dermal fibroblasts were exposed to UVB at 0 and
40 mJ cm–2. β -actin was used as an internal controlUVB in the skin. The induced ING1 protein may contribute to the
various cellular responses, such as apoptosis and DNA repair, after
UVB irradiation.
In this study, we found that wild-type p53 is not required for the
expression of ING1 in both normal and stress conditions, although
their partnership has been shown to be required for exerting
biological effects such as growth inhibition and apoptosis
(Garkavtsev et al, 1998; Shinoura et al, 1999). The UV induction
of ING1 seen in our keratinocytes therefore suggests two possibil-
ities: 1. ING1 is capable of responding to stress in terms of expres-
sion independent of p53 but cannot perform its cellular activities
without the functional p53; and 2. ING1 is capable of responding
to stress and carries out its functions independent of p53. Further
functional studies are needed to decipher the role of ING1 in
cellular stress response. Because we have previously shown that
p53 gene knockout predisposes animals to UV-induced skin cancer
development, reduces UV-damaged DNA repair, and lowers the
apoptotic rate (Li et al, 1995; 1996; 1997; 1998a; Tron et al,
1998b), investigations on how ING1 cooperates with p53 in
keratinocytes to modulate cell cycle arrest, DNA repair, and apop-
tosis will further determine the functional significance of ING1 in
UV-induced stress response in particular and skin carcinogenesis
in general. To support the notion that ING1 plays a role in skin
carcinogenesis, we have recently found that UV-induced murine
squamous carcinomas express significantly higher levels of ING1
regardless of p53 status in comparison to normal skin (data not
shown). Although current mutational studies indicate that very
few alterations are found in ING1 gene in breast, ovarian, and
gastric cancers (Ohmori et al, 1999; Oki et al, 1999; Toyama et al,
1999), ING1 mutation may only be specific to UV-induced skin
cancers. Future studies on ING1 mutational status in skin tumours
will help reveal the nature of its ING1 induction.
Taken together, our results demonstrate that ING1 expression
is independent of p53 status and that UV-induction of ING1 in
human keratinocytes suggests a role of ING1 in cellular stress
response and skin carcinogenesis.
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